Image

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Recruiting
12-19 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.

Description

A device has been developed for sensing volatile organic compounds (VOCs) from human breath. VOCs are chemicals in the air that make up scents and smells, and many VOCs are endogenously produced inside the human body. Trained dogs can smell exhaled breath to determine if someone has diabetes and can even distinguish hypo- or hyperglycemic events (low or high blood sugar). The purpose of this study is to determine if the sensor device can identify hypo- or hyperglycemic events in persons with diabetes through detecting VOCs in breath noninvasively. The data obtained from the VOC sensor will be compared to the information that is also gathered from a continuous glucose monitor (CGM) to establish correlations between blood glucose and exhaled VOC measurements.

Eligibility

Inclusion Criteria:

  • Who are diagnosed with type 1 diabetes.
  • Who are between 12-19 years of age.
  • That utilize a Dexcom (G6 or G7) continuous glucose monitoring device.
  • That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours).
  • That are willing to share their daily CGM data for the study.
  • That are the only individuals in their household with any type of diabetes diagnosis (type 1 or type 2).
  • That are willing to return the device within 24-48 hours of study completion.
  • That are located in Indianapolis, IN or its suburban areas.

Exclusion Criteria:

  • That are smokers or use tobacco products or who live with someone who smokes in their vicinity.
  • That have a condition or abnormality other than type 1 diabetes that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data.
  • That utilize closed-loop diabetes management systems.
  • That have symptoms or recently been diagnosed with an upper respiratory illness including COVID-19.
  • That themselves or a close family member (living within the same household at the time of the data collection period) is on a "ketogenic diet".
  • That themselves or a close family member is working in an industry with high and continuous exposure to exogenous VOCs. Examples of such industries include beauty salons and paint manufacturers.
  • That are unable or unwilling to cooperate with sample collection.

Study details
    Diabetes
    Hyperglycemia
    Hypoglycemia

NCT06893341

Indiana University

1 November 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.